Richard Seist to Morpholines
This is a "connection" page, showing publications Richard Seist has written about Morpholines.
Connection Strength
0.169
-
Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. Sci Rep. 2020 03 06; 10(1):4211.
Score: 0.169